logo

Stock Screener

Forex Screener

Crypto Screener

CVS

CVS Health Corporation (CVS)

$

72.14

+0.21 (0.29%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

3.7757

Market cap

Market cap

91.2 Billion

Price to sales ratio

Price to sales ratio

0.2360

Debt to equity

Debt to equity

1.0691

Current ratio

Current ratio

0.8034

Income quality

Income quality

1.6840

Average inventory

Average inventory

17.4 Billion

ROE

ROE

0.0595



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

CVS Health Corporation provides a comprehensive range of health services across the United States, demonstrating its commitment to meet the diverse needs of its clientele. The company’s Health Care Benefits segment offers a variety of health insurance products, including traditional, voluntary, and consumer-directed options, aimed at employer groups, individuals, college students, part-time workers, and various other organizations such as health plans and governmental units. With a net income ratio of 0.01 reflecting its profitability margin, CVS Health showcases its financial strength through an operating income of $8,516,000,000.00 indicative of its core operational earnings. The company earned an interest income of $0.00 showcasing its financial investments and ability to generate revenue outside its primary services. Additionally, the gross profit stands at $51,401,000,000.00 highlighting the effectiveness of its core operations. In its Pharmacy Services segment, CVS Health offers pharmacy benefit management solutions, including plan design, formulary management, and specialty pharmacy services, catering to a wide range of clients from employers to individuals. This segment plays a crucial role in managing medication needs and delivering tailored health care solutions. As of December 31, 2021, CVS Health operated approximately 9,900 retail locations and 1,200 MinuteClinic facilities, further affirming its extensive presence in the health care market. Within the financial landscape, CVS Health's stock is identified with the symbol 'CVS', attracting a variety of investors. The stock is affordable at $64.36 suitable for budget-conscious investors, while its high average trading volume of 7,397,036.00 indicates strong liquidity. With a large market capitalization of $91,497,326,200.00 the company stands as a dominant player in the health services industry, contributing significantly to the overall market landscape. As it belongs to the Healthcare sector, CVS Health is instrumental in driving innovation and growth, shaping the future of health care delivery and access. This strategic positioning not only enhances its market influence but also ensures it remains a pivotal force within the evolving health care industry.

What is CVS Health Corporation (CVS)'s current stock price?

The current stock price of CVS Health Corporation (CVS) is $72.59 as of 2025-08-29. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in CVS Health Corporation (CVS) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bullish outlook. Always conduct your own research before investing.

Analysts predict CVS Health Corporation stock to fluctuate between $43.56 (low) and $72.51 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-08-29, CVS Health Corporation's market cap is $91,497,326,200, based on 1,268,330,000 outstanding shares.

Compared to Eli Lilly & Co., CVS Health Corporation has a Lower Market-Cap, indicating a difference in performance.

CVS Health Corporation pays dividends. The current dividend yield is 4.35%, with a payout of $0.67 per share.

To buy CVS Health Corporation (CVS) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CVS. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.

CVS Health Corporation's last stock split was 2:1 on 2005-06-07.

Revenue: $372,809,000,000 | EPS: $3.66 | Growth: -43.61%.

Visit https://www.cvshealth.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $111.25 (2022-02-08) | All-time low: $43.56 (2024-12-23).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

CVS

zacks.com

CVS Health Services' Q2 AOI Falls Despite Sales Gain: More Risk Ahead?

CVS Health's Q2 Health Services revenues climb 10%. Yet, AOI slips as cost pressures and Oak Street's rising MBR ail.

CVS

youtube.com

CVS is up because it faced the pain that's now hitting the rest of managed care, says Jim Cramer

'Mad Money' host Jim Cramer takes a look at CVS and what is driving the stock up.

CVS

youtube.com

Jim Cramer talks what is driving CVS higher this year

'Mad Money' host Jim Cramer takes a look at CVS and what is driving the stock up.

CVS

zacks.com

CVS Gains in Pharmacy & Consumer Wellness Despite Reimbursement Woes

CVS Health's Pharmacy & Consumer Wellness unit posts double-digit revenue gains despite ongoing reimbursement headwinds.

CVS

zacks.com

4 Value Stocks Every Investor Should Hold in Volatile Times

StoneCo, CVS, Integer Holdings and USANA emerge as attractive value stocks with low cash-flow ratios and solid growth outlooks.

CVS

reuters.com

Exclusive: CVS holds off adding Gilead's new HIV prevention shot to drug coverage lists

CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite the medicine's proven effectiveness.

CVS

zacks.com

Should You Invest in CVS Health (CVS) Based on Bullish Wall Street Views?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

CVS

seekingalpha.com

CVS Health: Outlier In Healthcare Implosion - Further Margin Recovery Ahead

CVS has emerged as an outlier during the ongoing implosion observed in the healthcare insurance sector, as they drive improved YoY margins despite the rising medical costs. This is on top of the somewhat stable performance metrics observed in the PBM and pharmacy end markets, as the management confidently raises the FY2025 adj EPS guidance. These directly contrast the massive pessimism observed in CVS' healthcare peers, where CEO is being replaced and FY2025 guidance has been cut/ suspended.

CVS

seekingalpha.com

CVS Health: Health Insurers Get Buffett's Stamp Of Approval (Rating Upgrade)

Super investors like Buffett and Michael Bury piled heavily into UnitedHealthcare in Q2, signalling confidence that the sector's business model remains intact despite recent headwinds. CVS has emerged as a top performer in 2025, with strong revenue growth and raised guidance, outpacing struggling peers like UnitedHealth. The sector faces ongoing uncertainties—rising costs, regulatory scrutiny, and budget cuts—but long-term healthcare spending trends remain favorable.

CVS

zacks.com

CVS Advances Digital Efforts to Simplify Healthcare Experience

CVS Health commits $20B to build an open health platform, joining tech giants in a push to streamline patient care access nationwide.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener